2/25/25: Invivyd chairman Marc Elia; Long COVID in Mexico

In this episode of Still Here: Invivyd chairman Marc Elia speaks with co-host Miles Griffis about his recent op-ed for The Sick Times about how bureaucracy is killing people with Long COVID and the role of monoclonal antibodies in the ongoing pandemic. And freelance health and science reporter Annika Hom speaks with co-host Betsy Ladyzhets about efforts to establish a national clinical guideline for treating Long COVID in Mexico.Also in this episode: A phase III Long COVID clinical trial testing a combination of the HIV drug Selzentry (Maraviroc) and the statin Lipitor (Atorvastatin), and the latest COVID-19 trends. The transcript for this podcast is⁠⁠ available on The Sick Times’ website⁠⁠. You can jump to specific sections of the podcast and transcript below:(00:00:00) Intro(00:01:37) COVID-19 trends(00:05:12) Invivyd chairman Marc Elia on monoclonal antibodies and more(00:18:36) Long COVID clinical guideline in Mexico (00:26:55) Research: Phase III Long COVID clinical trial with a HIV drug-statin combination(00:28:46) OutroYou can also find our podcast on⁠⁠ Apple Podcasts⁠⁠, ⁠⁠Pocket Casts⁠⁠, ⁠⁠Amazon Music⁠⁠, ⁠⁠and iHeartRadio⁠⁠.Mentioned in this episode (in order of appearance): The Sick Times: National COVID-19 trends, February 18CDC wastewater dashboardBiobot wastewater risk reportsWastewaterSCAN dashboardThe Sick Times: Invivyd Chairman Marc Elia: The bureaucracy is killing people with Long COVIDThe Sick Times: Frustrations, denials, long drives: Immunocompromised people can’t access a lifesaving COVID-19 drugThe Sick Times: Without clear clinical guidelines in México, people with Long COVID face gaslighting and erasureThe Sick Times: Research updates, February 18Additional audio used in this episode (in order of appearance):Rude Mechanical Orchestra: Which Side Are You On? (orig. Florence Reece) Pixabay: Thunder and the beginning of rainfall